Hemolytic Anemias

Hemolytic anemias are a group of blood disorders characterized by the destruction of red blood cells (RBCs) at a rate that exceeds their production. This results in a decrease in the number of RBCs circulating in the blood, which can lead to a variety of symptoms such as fatigue, shortness of breath, and decreased exercise tolerance. There are several different types of hemolytic anemias, each with its own underlying cause. Some of the most common forms of hemolytic anemias include autoimmune hemolytic anemia (AIHA), hereditary spherocytosis, and sickle cell anemia. AIHA occurs when the body's immune system produces antibodies that attack and destroy its own RBCs. Hereditary spherocytosis is a genetic condition that causes RBCs to be abnormally shaped, making them more prone to destruction. Sickle cell anemia is a genetic disorder in which RBCs are abnormally shaped and prone to obstructing blood flow and undergoing premature destruction. Diagnosis of hemolytic anemias typically involves a complete blood count (CBC) and blood smear, as well as additional testing such as a Coombs test, which can help identify the underlying cause of the anemia. Treatment for hemolytic anemias depends on the underlying cause and severity of the disease, but may include blood transfusions, medication to suppress the immune system, or surgical removal of the spleen (which is responsible for removing damaged RBCs from the bloodstream). Research in the fields of hematology and oncology is ongoing, with a focus on developing new treatments for hemolytic anemias and other blood disorders, as well as understanding the complex mechanisms that lead to the destruction of RBCs.

Related Topics

Lung Cancer

Blood Pressure

Protein s Deficiency

Global Oncology

Women s Health Gynecological Cancers

Mixed Müllerian Tumor

Blood